JPRN-UMIN000031667已完成未知
Clinical Safety and Effectiveness of Tolvaptan for patients with heart falure - Clinical Safety and Effectiveness of Tolvaptan
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 317
研究概览
简要总结
After multiple adjustments, there were no significant differences for overall survival and rehospitalization between the groups.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 110years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
ongitudinal Efficacy and Safety Study of Tolvaptan on Autosomal Dominant Polycystic Kidney Disease PatientsAutosomal Dominant Polycystic Kidney DiseaseJPRN-UMIN000021267Autosomal Dominant Polycystic Kidney Disease Research Section, Kyorin University, School of Medicine119
已完成
不适用
Efficacy and safety of tolvaptan for better management of patients undergoing liver resection, prospective studyprimary liver cancerJPRN-UMIN000041684Toranomon hospital50
招募中
不适用
A study to evaluate effect and safety of Tolvaptan in Nephrogenic Diabetes Insipidus caused by mutations in the vasopressin type 2 receptor gene.ephrogenic Diabetes Insipidus caused by mutations in the vasopressin type 2 receptor geneJPRN-UMIN000021708Department of Nephrology and Endocrinology, The University of Tokyo Hospital3
已完成
不适用
Comparison of Tolvaptan treatment and conventional treatment in elderly acute heart failure.Acute decompensated heart failureJPRN-UMIN000028039Iiyama redcross hospital60
已完成
3 期
Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)Autosomal Dominant Polycystic Kidney Disease (ADPKD)NCT02964273Otsuka Pharmaceutical Development & Commercialization, Inc.91